Share on
Overview
Inova Health is a US health system. Since 2020, Inova and Genesis have worked together to transform implant spend management, showing that clinical excellence and surgeon choice can thrive alongside disciplined cost control. Through strategic alignment, technology integration, and disciplined process improvement, the partnership has delivered substantial financial, operational, and strategic value across the health system.
What began as a single implant category has grown into a system-wide programme spanning 14 surgical categories, more than $17 million in cost savings, and over 50,000 surgical cases processed each year. The challenges Inova tackled, price variation between sites, manual processing of bill-only and consignment implants, and supplier contract compliance, are shared by NHS trusts and independent providers managing high-cost implants across multiple hospitals.
The Challenge
High-cost implant spend is one of the largest and least-controlled cost lines in any hospital group. Like many multi-site organisations, Inova was paying different prices for the same implants at different hospitals. Bill-only cases required manual entry and review before a purchase order could be issued, and checking each supplier charge against contract terms was slow and inconsistent. Excess inventory added further cost.
The goal was clear: bring implant spend under control without asking surgeons to give up the products they rely on.
The Approach
Inova and Genesis started with a single implant category and built the programme on three disciplines:
- Price standardisation: one unified pricing structure across every hospital.
- Automation: Genesis integrated with Inova’s ERP so bill-only implant cases are adjudicated up front, before payment.
- Supplier accountability: automated alerts flag potential overcharges, and contract terms are enforced across every supplier.
Alongside the technology, Genesis experts provide ongoing knowledge transfer and training so Inova’s own team builds lasting internal expertise.
Financial Impact: 2020 to 2024
The partnership has generated more than $17 million in cost savings across multiple implant categories, with $9 million achieved in the initial implementation phase. These savings were made possible through disciplined price standardisation, automation, and supplier accountability, not by restricting surgeon choice.
- $17M+ in total cost savings delivered
- $9M in savings during initial implementation
- $450K in potential overcharges prevented through automated alerts
- Up to 30% reduction in price variation across sites
- 25% decrease in excess inventory-related costs
Operational Improvements
Genesis has enabled end-to-end automation of bill-only implant processes, integrating with Inova’s ERP to streamline adjudication and supplier compliance. These improvements have significantly enhanced internal efficiency.
- Full bill-only automation across multiple service lines
- ERP integration with up-front adjudication
- 98% billing accuracy achieved through automated workflows
- 35 to 40% reduction in manual administrative processing time
- 135 supplier contracts actively managed through the platform
- 85% reduction in contract compliance issues
- 50,000+ surgical cases processed each year, with reporting on savings, utilisation, and trends
Strategic Transformation
What began with a single category implementation has evolved into a system-wide transformation, now spanning 14 surgical categories, including trauma, craniomaxillofacial (CMF), biologics, and breast reconstruction. The partnership has laid the foundation for a sustainable supply chain model built on data transparency, clinical engagement, and long-term value.
- Expansion from the initial use case to 14 surgical categories
- Unified pricing structure established across all sites
- Integrated ERP systems automate formerly manual workflows
- EPR integration in progress to reduce manual review for clinical auditors
- Ongoing knowledge transfer and training to develop internal expertise
- A framework for sustainable, long-term cost control
- Real-time analytics that support a data-informed culture
Looking Ahead
The Inova and Genesis partnership continues to evolve, with active initiatives in craniomaxillofacial (CMF), trauma, and breast reconstruction. These initiatives build on the proven foundation already in place and represent the next phase in implant cost management and operational efficiency.
This case shows what is possible when clinical, financial, and operational teams work towards a shared vision: measurable impact today, and a more sustainable health system for tomorrow.
About Genesis
Genesis Automation Healthcare is the Clinical Lifecycle Management Platform, closing the gap between the ERP and the EPR. One supplier-neutral platform brings together Genesis Data, Sourcing, Inventory, Clinical, Savings, and Intelligence to help NHS trusts, independent providers, and health systems protect patient safety and margins across every stage of the clinical supply lifecycle. Genesis is trusted by 400+ hospitals and health systems.
See what your implant spend could save.
Talk with a Genesis expert about where high-cost implant spend is leaking today, and what a programme like Inova’s could look like for your trust or hospital group.
